Page last updated: 2024-10-15

flm 5011

Cross-References

ID SourceID
PubMed CID136029274
SCHEMBL ID10382716
MeSH IDM0165581

Synonyms (4)

Synonym
flm 5011
105634-48-8
flm-5011
SCHEMBL10382716

Effects

ExcerptReference
"FLM 5011 has been shown to be protective against arachidonic acid-induced bronchoconstriction in vitro and in vivo."( Antiinflammatory effect of a lipoxygenase inhibitor (FLM 5011) in severe active myocarditis.
Förster, A; Geissler, W; Meyer, R; Rapoport, SM; Reisinger, I; Romaniuk, P; Schewe, T; Slapke, J, 1988
)

Treatment

ExcerptReference
"FLM 5011 treatment reduced the endothelial edema, blebbing and occurrence of pericapillary debris and stabilized the number of vesicles."( Lipoxygenase inhibitor FLM 5011, an effective protectant of myocardial microvessels against ischemia-reperfusion injury? An ultrastructural-morphometric study.
Fitzl, G; Mark, B; Welt, K, 2000
)

Bioavailability

ExcerptReference
" The bioavailability of 1 in rabbits after oral administration is markedly increased using 1-prodrugs studied."( [Improvement of the absorption of the active substance 2'-hydroxy-5'-methyllaurophenoxamine (FLM 5011) with prodrugs and preparations].
Fries, G; Fürst, W; Lücke, L; Neubert, R; Tscheuschner, C, 1993
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (14.29%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]